Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer

Journal of Clinical Oncology

Volumn 12, Issue 2, 1994, Pages 385-395

  Taylor IV, S G ^a   Murthy, A K ^b   Vannetzel, J M ^b   Colin, P ^b   Dray, M ^b   Caldarelli, D D ^b   Shott, S ^b   Vokes, E ^b   Showel, J L ^b   Hutchinson, J C ^b   Witt, T R ^b   Griem, K L ^b   Hartsell, W F ^b   Kies, M S ^b   Mittal, B ^b   Rebischung, J L ^b   Coupez, D J ^b   Desphieux, J L ^b   Bobin, S ^b   LePajolec, C ^b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; KIDNEY DISEASE; LARYNX EDEMA; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY FAILURE; SKIN TOXICITY; SQUAMOUS CELL CARCINOMA; VASCULAR DISEASE; VOMITING; WEIGHT REDUCTION;

EID: 0028158540     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1994.12.2.385     Document Type: Article

References (33)

1. Ervin TJ, Weichselbaura RR, Fabian RL, et al: Advanced squamous carcinoma of the head and neck. A preliminary report of neoadjuvant chemotherapy with cisplatin, bleomycin, and methotrexate. Arch Otolaryngol Head Neck Surg 110:241-245, 1984
2. Louie KG, Behrens BC, Kinsella TJ, et al: Radiation survival parameters of antineoplastic drug-sensitive and resistant human ovarian cancer cell lines and their modification by buthionine sulfoximine. Cancer Res 45:2110-2115, 1985
3. Wallner KE, Li GC: Effect of cisplatin resistance on cellular radiation response. Int J Radiat Oncol Biol Phys 13:587-591, 1987
4. Jacobs JR, Weaver A, Ahmed K, et al: Proto-chemotherapy in advanced head and neck cancer. Head Neck Surg 10:93-98, 1987
5. Frei E III, Clark JR, Fallon BG: Guidelines, regulations and clinical research. J Clin Oncol 4:1026-1030, 1986
6. Stell PM, Rawson NSB: Adjuvant chemotherapy in head and neck cancer. Br J Cancer 61:779-787, 1989
7. Paccagnella A, Orlando A, Marchiori C, et al: A phase III trial of neoadjuvant chemotherapy in head and neck cancer. Proc Am Soc Clin Oncol 12:278, 1993 (abstr)
8. Ansfield FJ, Ramirez G, Davis HL Jr, et al: Treatment of advanced cancer of the head and neck. Cancer 25:78-82, 1970
9. Gupta NK, Pointon RCS, Wilkinson PM: A randomized clinical trial to contrast radiotherapy with radiotherapy and methotrexate given synchronously in head and neck cancer. Clin Radiol 38:575-581, 1987
10. Fu KK, Phillips TL, Silverberg IJ, et al: Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: Update of a Northern California Oncology Group randomized trial. J Clin Oncol 5:1410-1418, 1987
11. Weissberg JB, Son YH, Papac RJ, et al: Randomized clinical trial of mitomycin C as an adjunct to radiotherapy in head and neck cancer. Int J Radiat Oncol Biol Phys 17:3-9, 1989
12. Bachaud J-M, David J-M, Boussin G, et al: Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced squamous cell carcinoma of the head and neck: Preliminary report of a randomized trial. Int J Radiat Oncol Biol Phys 20:243-246, 1991
13. Taylor SG IV, Murthy AK, Caldarelli DD, et al: Combined simultaneous cisplatin/5-FU infusion chemotherapy and split course radiation in head and neck cancer. J Clin Oncol 7:846-856, 1989
14. Pajak TF, Fazekas JT, Davis, LW, et al: Analysis of Radiation Therapy Oncology Group head and neck cancer data base: Identification of prognostic factors and the re-evaluation of American Joint Committee staging system, in Vogl S (ed): Head and Neck Cancer. New York, NY, Churchill Livingstone, 1988, pp 41-64
15. Oken MM, Creech RH, Douglas CT, et al: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649-655, 1982
16. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
17. Peto R, Peto J: Asymptomatically efficient rank invariant test procedures. J R Stat Soc A 135:185-198, 1972
18. Cox DR: Regression models and life tables (with discussion). J R Stat Soc B 34:187-198, 1972
19. Adelstein DJ, Sharon VM, Earle AS, et al: Simultaneous versus sequential combined technique therapy for squamous cell head and neck cancer. Cancer 65:1685-1691, 1990
20. Merlano M, Corvo R, Margarino G, et al: Combined chemotherapy and radiotherapy in advanced inoperable squamous cell carcinoma of the head and neck. Cancer 67:915-921, 1991
21. SECOG: A randomized trial of combined multidrug chemotherapy and radiotherapy in advanced squamous cell carcinoma of the head and neck. Eur J Surg Oncol 12:289-295, 1986
22. Merlano M, Vitale V, Rosso R, et al: Improved survival of patients with advanced squamous cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. N Engl J Med, 1992. Treatment of advanced squamous cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. N Engl J Med 327:1115-1121, 1992
23. Taylor SG IV, Applebaum E, Showel JL, et al: A randomized trial of adjuvant chemotherapy in head and neck cancer. Arch Otolaryngol 109:544-549, 1983
24. Head and Neck Contracts Program: Adjuvant chemotherapy for advanced head and neck squamous carcinoma. Final report of the Head and Neck Contracts Program. Cancer 60:301-311, 1987
25. Withers HR, et al: The hazard of accelerated tumor clonogen repopulation during radiation therapy. Acta Oncol 27:131-146, 1988
26. Elkind MM: Fractionated dose radiotherapy and its relationship to survival curve shape. Cancer Treat Rev 3:1-15, 1976
27. Wiley AL Jr, Ramirez G, Johnson RO, et al: Treatment of carcinoma of base of tongue with radiation therapy and 5-fluorouracil. Acta Radiol Oncol 18:235-243, 1979
28. Jacobs C, Mekuch R: Efficacy of adjuvant chemotherapy for patients with resectable head and neck cancer: A subset analysis of the Head and Neck Contracts Program. J Clin Oncol 8:838-847, 1990
29. Gradishar W, Vokes E, Schilsky R, et al: Vascular events in patients receiving high-dose infusional 5-fluorouracil-based chemotherapy: The University of Chicago experience. Med Pediatr Oncol 19:8-15, 1991
30. Taylor SG IV, Murthy AK, Showel JL: Improved control in advanced head and neck cancer with simultaneous radiation and cisplatin/5-FU chemotherapy. Cancer Treat Rev 69:938-939, 1985
31. Taylor SG IV, Trybula M, Bonomi PD, et al: Simultaneous cisplatin fluorouracil infusion and radiation followed by surgical resection in regionally localized stage III, non-small cell lung cancer. Ann Thorac Surg 43:87-91, 1987
32. Department of Veterans Affairs Laryngeal Cancer Study Group: Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324:1685-1690, 1991
33. Jacobs C, Goffinet DR, Goffinet L, et al: Chemotherapy as a substitute for surgery in the treatment of advanced head and neck cancer. Cancer 60:1178-1183, 1987